AstraZeneca PLC (AZN)
160.17
+0.53
(+0.33%)
USD |
NYSE |
Sep 11, 16:00
156.50
-3.67
(-2.29%)
After-Hours: 20:00
AstraZeneca Price : 160.17 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 161.43 | 161.51 | 158.13 | 160.17 | 2.229M |
| Sep 10, 2026 | 157.68 | 160.30 | 157.23 | 159.64 | 2.935M |
| Sep 09, 2026 | 158.31 | 159.13 | 156.74 | 156.94 | 3.874M |
| Sep 08, 2026 | 163.96 | 163.96 | 159.40 | 160.04 | 5.146M |
| Sep 04, 2026 | 162.82 | 163.78 | 161.13 | 162.70 | 3.073M |
| Sep 03, 2026 | 165.64 | 165.74 | 162.24 | 164.77 | 2.425M |
| Sep 02, 2026 | 162.54 | 164.69 | 160.87 | 161.63 | 3.301M |
| Sep 01, 2026 | 163.66 | 164.24 | 161.38 | 162.47 | 2.598M |
| Aug 31, 2026 | 162.70 | 163.75 | 161.95 | 162.13 | 3.068M |
| Aug 28, 2026 | 163.52 | 163.54 | 161.18 | 162.70 | 2.881M |
| Aug 27, 2026 | 165.27 | 165.58 | 163.98 | 164.52 | 2.495M |
| Aug 26, 2026 | 167.46 | 167.89 | 165.17 | 166.27 | 2.681M |
| Aug 25, 2026 | 167.08 | 170.18 | 166.78 | 169.66 | 3.454M |
| Aug 24, 2026 | 164.57 | 167.08 | 163.97 | 166.71 | 2.780M |
| Aug 21, 2026 | 164.04 | 167.25 | 163.96 | 165.98 | 3.180M |
| Aug 20, 2026 | 163.40 | 165.57 | 161.48 | 164.49 | 5.094M |
| Aug 19, 2026 | 162.13 | 165.91 | 162.00 | 164.95 | 3.818M |
| Aug 18, 2026 | 159.12 | 160.64 | 158.98 | 160.10 | 3.002M |
| Aug 17, 2026 | 156.30 | 157.26 | 155.78 | 156.89 | 3.362M |
| Aug 14, 2026 | 155.50 | 156.46 | 154.53 | 156.45 | 3.698M |
| Aug 13, 2026 | 157.85 | 158.44 | 156.97 | 157.24 | 3.598M |
| Aug 12, 2026 | 157.68 | 159.02 | 157.12 | 158.50 | 4.140M |
| Aug 11, 2026 | 162.06 | 162.26 | 158.61 | 158.75 | 2.755M |
| Aug 10, 2026 | 160.59 | 162.72 | 160.25 | 161.91 | 3.746M |
| Aug 07, 2026 | 162.14 | 162.18 | 160.00 | 161.42 | 3.721M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| GSK Plc | 48.13 |
| Johnson & Johnson | 265.58 |
| Eli Lilly & Co. | 1115.70 |
| Merck & Co., Inc. | 143.93 |
| Novo Nordisk A/S | 43.07 |
Price Related Metrics
| PE Ratio | 48.10 |
| PS Ratio | 8.269 |
| PEG Ratio | 1.414 |
| Price to Book Value | 10.50 |
| Price to Free Cash Flow | 62.11 |
| Earnings Yield | 2.08% |
| Market Cap | 496.79B |
| PEGY Ratio | 1.336 |
| Operating PE Ratio | 35.60 |
| Normalized PE Ratio | 47.55 |